Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers
1 other identifier
interventional
11
1 country
1
Brief Summary
The overall aim with this project is to investigate the effect of dexmedetomidine on control of breathing in healthy volunteers and to compare it with propofol at the same degree of sedation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started May 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 29, 2013
CompletedFirst Posted
Study publicly available on registry
June 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedFebruary 26, 2016
February 1, 2016
1.3 years
May 29, 2013
February 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hypoxic ventilatory response
Acute hypoxic ventilatory response,i.e. the ventilatory response to acute hypoxia measured as change in minute ventilation over change in peripheral oxygen saturation
One day for each drug; before,during and after sedation with dexmeditomidine or propofol
Secondary Outcomes (1)
hypercapnic ventilatory response
One day for each drug; Before, during and after sedation with dexmedetomidine or propofol
Other Outcomes (4)
upper airway obstruction
One day for each drug: Before, during and after sedation with dexmedetomidine or propofol
Plasma concentration
One day for each drug; At target sedation
Sedation level
One day; During the whole experimental procedure
- +1 more other outcomes
Study Arms (2)
Sedation with dexmedetomidine
EXPERIMENTALSedation with dexmedetomidine
Sedation with propofol
EXPERIMENTALSedation with propofol
Interventions
Eligibility Criteria
You may qualify if:
- Male
- Age 18-40
- American Society of Anesthesiologist´s classification (ASA) 1, i.e. healthy
- No medication
- No allergies
- Non-smoker/no snuff, i.e. no nicotine intake
- Normal weight, BMI \<26
You may not qualify if:
- Snoring
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology, Surgical Sciences and Intensive Care Medicine, Karolinska University Hospital
Stockholm, SE-17176, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malin Jonsson Fagerlund, MD, PhD
Karolinska University Hospital and Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
May 29, 2013
First Posted
June 10, 2013
Study Start
May 1, 2013
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
February 26, 2016
Record last verified: 2016-02